Experiences of postcardiotomy assist: pneumatic ventricular assist device or venoarterial bypass with percutaneous cardiopulmonary support

Artif Organs. 1996 Jun;20(6):721-3.

Abstract

From October 1982 to the present, 16 patients have been supported by a pneumatic ventricular assist device (VAD). Since April 1990, we have introduced a venoarterial bypass (VAB) with percutaneous cardiopulmonary support (PCPS) system. This PCPS system was used in 12 patients. The long-term survival rate of PCPS cases (41%) was much better than that of VAD cases (19%). The main cause of death in VAD cases was multiple organ failure (MOF). Although VAB was initiated more recently than VAD, the duration on support was longer in the VAD group than in the VAB group. Because of the longer support duration and the presence of many patients with MOF, coagulopathy deteriorated more readily in the VAD group than in the VAB group. In the case of postcardiotomy cardiopulmonary bypass weaning or low-output syndrome (LOS), the VAB with PCPS system should be applied first under intraaortic balloon pumping assist because of its simplicity and low cost. Thereafter, VAD should be applied in cases refractory to VAB support.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Cardiac Output / physiology
  • Cardiopulmonary Bypass / adverse effects
  • Cardiopulmonary Bypass / standards*
  • Cost-Benefit Analysis
  • Female
  • Heart-Assist Devices / adverse effects
  • Heart-Assist Devices / standards*
  • Hemorrhage / mortality
  • Humans
  • Intra-Aortic Balloon Pumping / adverse effects
  • Intra-Aortic Balloon Pumping / economics
  • Intra-Aortic Balloon Pumping / methods*
  • Male
  • Middle Aged
  • Multiple Organ Failure / epidemiology
  • Multiple Organ Failure / mortality
  • Postoperative Complications / epidemiology
  • Postoperative Complications / mortality
  • Shock, Cardiogenic / therapy*